Neurological outcome of a patient with Gaucher disease type III treated by enzymatic replacement therapy.
Dobbelaere
D
D
Unité des Maladies Métaboliques, Hôpital Jeanne de Flandre, Centre Hospitalier Régional Universitaire de Lille, France.
Sukno
S
S
Defoort-Dhellemmes
S
S
Lamblin
M D
MD
Largillière
C
C
D002675:Child, Preschool; D005500:Follow-Up Studies; D005776:Gaucher Disease / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D005962:Glucosylceramidase / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009460:Neurologic Examination; D016896:Treatment Outcome
C070292:alglucerase; D005962:Glucosylceramidase